Comparative Postoperative Complications of Acellular Dermal Matrix and Mesh Use in Prepectoral and Subpectoral One-Stage Direct to Implant Reconstruction: A Retrospective Cohort Study.
Abstract
[BACKGROUND] One-stage direct-to-implant (DTI) breast reconstruction is increasingly popular with the use of prepectoral reconstruction leading to increased demand for structural scaffolds. It is vital to determine if differences in safety profiles exist among scaffolds.
[METHODS] We performed a retrospective cohort study of consecutive patients in our breast cancer center undergoing DTI reconstruction. Outcomes relating to postoperative infections, wound complications, and implant related complications were extracted. Outcomes were grouped into major, minor, and long-term complications. Univariate and multivariate analysis determined outcome differences and accounted for confounding variables.
[RESULTS] Two hundred forty-two patients (404 breasts) underwent DTI reconstruction. One hundred ninety-two breasts were reconstructed with FlexHD Pliable Preformed (PP; MTF Biologics, Edison, NJ), 122 with AlloDerm Ready To Use (RTU; Allergan Aesthetics, Irvine, CA), 22 with DermACELL (LifeNet Health, Virginia Beach, VA), 21 with Galaflex (Galatea Surgical, Lexington, MA), 22 with Meso BioMatrix (MTF Biologics), and 25 with autologous dermal flaps alone. Univariate analysis demonstrated statistically significant differences among scaffolds in the incidence of cellulitis treated with oral antibiotics, capsular contracture, explantation for capsular contracture, seroma requiring operative drainage, minor complications, and long-term complications. On multivariate regression, FlexHD PP had reduced rates of capsular contracture, explantation for capsular contracture, minor complications, and long-term complications compared to AlloDerm RTU. Reconstruction with Galaflex had increased rates of capsular contracture when compared to FlexHD PP.
[CONCLUSIONS] Certain structural scaffolds have differing safety profiles that should be considered when selecting, which product to use in DTI reconstruction.
[METHODS] We performed a retrospective cohort study of consecutive patients in our breast cancer center undergoing DTI reconstruction. Outcomes relating to postoperative infections, wound complications, and implant related complications were extracted. Outcomes were grouped into major, minor, and long-term complications. Univariate and multivariate analysis determined outcome differences and accounted for confounding variables.
[RESULTS] Two hundred forty-two patients (404 breasts) underwent DTI reconstruction. One hundred ninety-two breasts were reconstructed with FlexHD Pliable Preformed (PP; MTF Biologics, Edison, NJ), 122 with AlloDerm Ready To Use (RTU; Allergan Aesthetics, Irvine, CA), 22 with DermACELL (LifeNet Health, Virginia Beach, VA), 21 with Galaflex (Galatea Surgical, Lexington, MA), 22 with Meso BioMatrix (MTF Biologics), and 25 with autologous dermal flaps alone. Univariate analysis demonstrated statistically significant differences among scaffolds in the incidence of cellulitis treated with oral antibiotics, capsular contracture, explantation for capsular contracture, seroma requiring operative drainage, minor complications, and long-term complications. On multivariate regression, FlexHD PP had reduced rates of capsular contracture, explantation for capsular contracture, minor complications, and long-term complications compared to AlloDerm RTU. Reconstruction with Galaflex had increased rates of capsular contracture when compared to FlexHD PP.
[CONCLUSIONS] Certain structural scaffolds have differing safety profiles that should be considered when selecting, which product to use in DTI reconstruction.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 합병증 | capsular contracture
|
피막구축 | dict | 5 | |
| 해부 | breast
|
유방 | dict | 2 | |
| 재료 | alloderm
|
무세포진피기질 | dict | 2 | |
| 해부 | Prepectoral
|
scispacy | 1 | ||
| 해부 | breasts
|
scispacy | 1 | ||
| 해부 | oral
|
scispacy | 1 | ||
| 합병증 | wound
|
scispacy | 1 | ||
| 합병증 | dermal flaps
|
scispacy | 1 | ||
| 합병증 | FlexHD PP
|
scispacy | 1 | ||
| 합병증 | seroma
|
장액종 | dict | 1 | |
| 합병증 | cellulitis
|
감염 | dict | 1 | |
| 재료 | acellular dermal matrix
|
무세포진피기질 | dict | 1 | |
| 약물 | [BACKGROUND] One-stage
|
scispacy | 1 | ||
| 약물 | Allergan
|
scispacy | 1 | ||
| 약물 | Galaflex
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 기법 | subpectoral
|
근막하 평면 | dict | 1 | |
| 질환 | breast cancer
|
C0006142
Malignant neoplasm of breast
|
scispacy | 1 | |
| 질환 | postoperative infections
|
C0392618
Postoperative infection
|
scispacy | 1 | |
| 질환 | contracture
|
C0009917
Contracture
|
scispacy | 1 | |
| 질환 | AlloDerm RTU
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | FlexHD
|
scispacy | 1 | ||
| 기타 | MTF
|
scispacy | 1 | ||
| 기타 | Edison
|
scispacy | 1 | ||
| 기타 | RTU
|
scispacy | 1 | ||
| 기타 | Irvine
|
scispacy | 1 | ||
| 기타 | DermACELL
|
scispacy | 1 | ||
| 기타 | BioMatrix
|
scispacy | 1 | ||
| 기타 | capsular
|
scispacy | 1 | ||
| 기타 | FlexHD PP
|
scispacy | 1 |
MeSH Terms
Humans; Retrospective Studies; Female; Acellular Dermis; Middle Aged; Postoperative Complications; Surgical Mesh; Breast Implantation; Adult; Breast Neoplasms; Breast Implants; Aged; Mammaplasty; Mastectomy; Treatment Outcome; Cohort Studies
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- The Plastic Surgery In-Service Examination: A Scoping Review.